# Pre-Operative Nodal Staging of Thyroid Cancer Using USPIO MRI: Preliminary Study

> **NCT01927887** · NA · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 12 (actual)

## Conditions studied

- Papillary Carcinoma of Thyroid Gland
- Metastatic Medullary Thyroid Cancer
- Follicular Thyroid Cancer Lymph Node Metastasis

## Interventions

- **DRUG:** Ferumoxytol
- **DEVICE:** Nanoparticle MRI

## Key facts

- **NCT ID:** NCT01927887
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2015-04
- **Final completion:** 2016-04
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01927887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01927887, "Pre-Operative Nodal Staging of Thyroid Cancer Using USPIO MRI: Preliminary Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01927887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*